Flash Player 9.0.0 is required for the Video Gallery.
Get Adobe Flash Player.
Colleague's E-mail is Invalid
Your message has been successfully sent to your colleague.
An immunotherapy treatment approach using the immune system’s natural killer cells has been effective in treating patients with recurrent leukemia and other difficult to treat blood cancers. Now, researchers at Washington University Siteman Cancer Center in St. Louis have shown in preclinical studies conducted in mice and human cells that this type of cell-based immunotherapy also could be effective against solid tumors, starting with melanoma. Ryan Fields, MD, a surgeon specializing in a surgical oncology and Todd Fehniger, MD, PhD, Bone Marrow Transplant Specialist, and Medical Oncologist discuss their recent findings and the transformation of cancer care at Siteman Cancer Center.